chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patients guardian falsified DOB when registering for vaccination. Guardian consented to the vaccination. Department of Health verified with statistical records that the patients actual DOB is exact date which made the vaccine a contraindication.  No known adverse reactions noted.
approx 2hr p/vax pt couldn't move rt arm, extremely painful w/movement, woke up all right;has been taking advil for approx q 6hr since vax;has not called or seen MD;
Myalgia, Fever, CoughWheeze Chills, Weakness, Pain to left arm Narrative:  Other Relevant History:
Rec'd nasal mist - nose burned, dizziness, headache, throat hurting. Later c/o feeling hot and stomach ache, but throat and nose burning resolved. Monitored for approx 45 min - parent contacted to pick up per students request.
Acute CVE with right side weakness & aphasia. Initial hospital stay 3/3/21-3/8/21. Transferred to rehabilitation facility 3/8/21-4/17/21.
3 days after second Covid 19 vaccine, June 11, had one nose bleed that bled "a lot"-  was bleeding out the front of the nose and just stopped on its own without any treatment.   Started  back up a week later with usually 2-3 times per day average time it lasts 10-15 minutes.   After about 3 days she stopped her Zyrtec and Flonase to see if it would help, it didn't seem to help.  She blows her nose, and will get out a larger clot-  now the bleeds just fill up the nostril-  has a big scab there.   She does have a large scab in the nose.  Right nostril only.  Remote history of nose bleeds-  however only 2 times previously-  around 7/8 years old related to trauma/dry nostrils-
Moderna COVID-19 Vaccine EUA Headache and fatigue lasting only the second day 1/27/20 only
Within 5-10 minutes of receiving the vaccine I began to have tachycardia and tightness in my chest and throat- airway remained clear but resembled tightness with asthma exacerbation. Dry cough developed as well at that time. Through the day severe body aches, fatigue and fever/chills developed and progressed. I was unable to sleep as a result. Today severs body aches and fever/chills continue as well as headache that does not resemble the chronic migraines I normally have. Tightness in chest and dry, nonproductive cough continue as well. I am also experiencing extreme fatigue. Injection site is hot, red, and raised- pain with left arm movement as a result.
Pulmonary embolism. First noticed shortness of breath in early to mid December.   Was traveling for the holidays.  Got an appt with cardiologist on 1/3.  He diagnosed and sent for CT scan.  Confirmed triple PE.
This case was reported by a nurse via sales rep and described the occurrence of influenza-like symptoms in an unspecified number of adolescent patients who received BEXSERO. On an unknown date, the patient received BEXSERO  (intramuscular) .5 ml. On an unknown date, less than a year after receiving BEXSERO, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was recovered/resolved. The reporter considered the influenza-like symptoms to be probably related to BEXSERO. Additional details were provided as follows: In 2016, several patients received BEXSERO and experienced flu-like symptoms. It was reported that even some other kids also experienced the symptoms. But no details were provided for the specific number of patients.
- has had fever, chills,  nausea, headache, joint pain, arm pain, numbness of hands & feet; rash over chest , and some shortness of breath
Post vax, she developed a fever and extreme soreness at the vax site. Beginning on the day she received the MMR vax, she lost cognitive skills. She was speaking about 7 words; they were all lost. She stopped trying to interact with people. She now displays many autistic symptoms. Treated with gluten and dairy free diet and as of one month ago. It will not cause her to recover, only to improve.
Patient reports getting a sinus infection and needing to taking antibiotics because she was only getting worse upon just trying to take acetaminophen and Mucinex.
Patient presented to clinic on 11/19/10 with a 3-day history of left-side facial numbness and drooping as well as trouble tasting food.
Patient presented 3 weeks after vaccination with massive bilateral femoral and portal visceral thrombosis. Taken to surgery and resected dead bowel. Thrombosis progressed and patient died after 2 days.
A report was received from a consumer's family member on 24Jan03 indicating that a 61 year old male vaccinee experienced arthritis, arthralgia, night fevers, rash, fatigue, malaise and red patches approx 3 days after receiving Fluvirin on 18Nov02. On approx the 21Nov02 the vaccinee experienced arthritis, arthralgia, night fevers, rash , fatigue, and malaise. The vaccinee developed aching joints which limited his mobility. The vaccinee subsequently developed raised warm red patches around his knees as well as fevers at night and generalized malaise/fatigue. The vaccinee self medicated with ibuprofen and naproxen but the condition worsened over time. The vaccinee saw a physician on 15Jan03. The reporter indicated that the physician stated that the vaccinees experience was not performed and the only abnormalities were an elevated sedimentation rate of 42 (normal:0-20) and a positive anti-nuclear antibody test (1:160). The physician diagnosed the condition as an arthritis flare up and course of prednisone, but symptoms resumed upon discontinuation. At the time of the report the vaccinee was considering consulting a rheumatologist to confirm diagnosis of arthritis. The vaccinee had not recovered at the time of the report.
3/21-Facial & throat itching -09:26a 3/22-Localized reaction swelling  & rash on left arm
Severe allodinia, severe muscle and joint pain,  low grade fever, nausea and severe dizziness. Lasted 24hours.  Then severe dizziness and moderate nausea ongoing.
Narrative:  Patient received second COVID-19 vaccine (Pfizer) on 04/14/21. Within 7 mins, patient reported a feeling of throat closing, Vitals right after vaccine given were BP 118/88, HR 99, O2 100% room air, RR 24. After pt report of throat closing, 50mg/1mL Benadryl administered via injection to right deltoid. Vitals were BP 111/85, HR 84, O2 99% room air, RR 18 at this point. After Benadryl, pt reports feeling better. Five mins later reports throat tightness again, so sent to ED. Pt reports allergy to rabbits. in ED given prednisone 60mg PO, famotidine 20mg IV. Patient recovered in ED and was discharged.
She developed large red/pink area around the injection site that was about 2.75 inches across with irregular border. She woke up on 3/8/18 with just a small red area, but by noon the area increased to the 2.75 inches across and appears to be increasing in size. There is swelling that radiates from the shoulder to the elbow. The reddened area is very warm to the touch. She has discomfort if she moves her arm up and down.
Intestinal cramping followed by explosive diarrhea at 3pm and again at 7pm.  Very tired.  Went to bed early around 8:30pm.  Woke up with headache and chills at 3:15am.  Took temperature - no fever (98.0).  Went back to sleep until 6am.  Woke up with a headache and chills again and took temperature again - no fever (98.6).  Could only stomach ginger tea.  Attended a computer work meeting at 7am, and couldn't stay awake after that.  Was back in bed before 8am.  Slept until 10:45am (24 hours after injection) and woke up feeling OK and hungry.  It's now 1:45 pm April 8, and I feel mostly fine but still unusually tired.
adverse reaction to Shingrix vaccine; This case was reported by a pharmacist via call center representative and described the occurrence of adverse reaction in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 29th March 2019, the patient received Shingrix. On an unknown date, less than a year after receiving Shingrix, the patient experienced adverse reaction. On an unknown date, the outcome of the adverse reaction was unknown.   It was unknown if the reporter considered the adverse reaction to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported, however it was captured as adult as per vaccine indication. The patient received Shingrix and experienced an unspecified adverse reaction.
Patient is 14 years old and was receiving 4 vaccines including TDaP, varicella, meningococcal, and hepatitis A. Patient was mistakenly given adult dose of hepatitis A vaccination. Family made aware of mistake.
extremely sick; other side effects that were listed; very high fever; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (extremely sick), ADVERSE EVENT (other side effects that were listed) and PYREXIA (very high fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNK) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (extremely sick), ADVERSE EVENT (other side effects that were listed) and PYREXIA (very high fever). At the time of the report, ILLNESS (extremely sick), ADVERSE EVENT (other side effects that were listed) and PYREXIA (very high fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
INSOMNIA; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced insomnia. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of insomnia was not reported. This report was non-serious. This case, from the same reporter is linked to 20210422203.
Rash. Had evaluation on 2/1/2012. Noted to have diffuse dark red papules on back and sides and a few on abdomen. Rash was determined as viral vs. MMR reaction. Also referred to Dermatology.
This case was reported by a nurse via sales rep and described the occurrence of influenza-like symptoms in a female patient who received SHINGRIX for prophylaxis. On 2nd May 2018, the patient received the 1st dose of SHINGRIX. On 2nd May 2018, less than a day after receiving SHINGRIX, the patient experienced influenza-like symptoms, injection site erythema, injection site swelling and injection site pain. On an unknown date, the outcome of the influenza-like symptoms was recovered/resolved and the outcome of the injection site erythema and injection site pain were not recovered/not resolved and the outcome of the injection site swelling was recovering/resolving. It was unknown if the reporter considered the influenza-like symptoms, injection site erythema, injection site swelling and injection site pain to be related to SHINGRIX. Additional details were provided as follows: This case was reported by the nurse for herself. The age at vaccination was not reported. The patient experienced redness, swelling and pain at the administration site. Symptoms began the day of vaccination. In 2018, less than a year after receiving SHINGRIX the patient experienced flu-like symptoms for a few days following the vaccine. At the time of this report, the swelling went down but redness and pain persisted. The reporter agreed to be followed up. This case has been linked with US2018GSK152347, reported by same reporter.
pt brought to ER w/fever 102.1 R had sx on 12JAN93 was treated next day; OM;
11NOV93 pt called to report diarrhea & vomiting & body aches starting @ 1PM p/vax; fever & red whelps on arms elbow to wrist, bumpy & sore; taken ASA referred to MD; to ER--spastic colon, having chills & hunger;
Initial unsolicited report received from a pharmacist on 08-Sep-2017. This case involves a 65-year-old female patient who was vaccinated with first injection of FLUZONE HD (Batch number: UI845AB, expiration date, dose and site of administration were not reported) intramuscularly on an unspecified date a few days ago. The patient did not have any pre-existing physician diagnosed allergies, birth defects, medical conditions (specify) and illness at the time of vaccination. Concomitant medications were not reported. On 09-Aug-2017, after the vaccination, the patient developed two lumps which were size of a small palm that were red and hot to the touch, one under the arm and the other at the elbow on the injection side and the area was connected by a diffuse red rash. The reported stated that the patient was not a cooperative patient and moved during the injection. The patient was advised to seek medical attention this A.M. over the phone and the reporter came in for her to evaluate it this afternoon and had yet to seek medical attention but, would advise it again. The patient required emergency room (ER)/ doctor visit. Laboratory investigations were reported as none. Corrective treatment was not reported. The outcome of all the events was reported as not recovered. List of documents held by sender: none.
Fever, diarrhea, sweating, cough, dizzy, fainting spell. Symptoms started 6 hours after administration - stopped 14 hours later. Unsure it may be a virus going around.
Aching body; Head ache; Nausea; Sore arm; Very tired; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: Er8734) via an unspecified route of administration in the right arm on 05Apr2021 at 12:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included depression, arthritis, Gastroesophageal reflux disease (GERD) and covid-19. The patient had no known allergies. Concomitant medications included esomeprazole magnesium (MANUFACTURER UNKNOWN), vaccinium macrocarpon (CRANBERRY EXTRACT) and calcium (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 13:00, the patient experienced head ache, nausea, aching body, sore arm and very tired. The adverse events did not result in doctor or other healthcare professional office/clinic visit/ emergency visit. The patient did not receive any treatment for the events. The clinical outcome of the events head ache, nausea, aching body, sore arm and very tired were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Patient received Moderna as first dose 01/13/2022 but on 03/24/2022 received Pfizer for 2nd dose in primary series, administered by her provider. As of today 03/28/2022 no report adverse reaction or outcome and no treatment required. She works at clinic.
Severe pain in left shoulder blade area started three days after second vaccine.  Has not  subsided.  Seems to be getting worse   Vaccine was administered to left arm
A non-serious spontaneous report of administration of expired FLUMIST was received from a physician concerning a 35-month-old patient. Neither relevant medical history nor concomitant medications have been reported for these patients. The product expired in 11-Dec-2011. The patient received expired FLUMIST 12-Dec-2011. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved. This case will be submitted in accordance with MedImmune's FLUMIST post-marketing commitment for the indicated population of 2 years to 59 months of age. There was no late occurring adverse event reported was added.
Information has been received regarding a case in litigation concerning a male child who, for the first two years of his life, was vaccinated with injections containing the "dangerous and highly toxic" mercury based preservative thimerosal. The alleged result of these vaccinations is that the pt now suffers from, and in the future will continue to suffer from, the toxic neurological effects of mercury poisoning. Immunization records were received which stated that on 12/01/97, the pt was vaccinated in the right arm with hep b vaccine recombinant (lot 623673/0879E; lot numbers not reported for doses given on 02/16/97 and 06/23/98), MMR vaccine II live (lot 0834L given in the right thigh on 09/28/98), varicella virus vaccine live (lot not reported given on 12/07/97), IPOL (lot M1295 given in the left arm on 12/01/97; lot and manufacturer not reported for dose given on 02/16/98), Orimune (lot 0796T given on 0503/99), Tripedia (lot 7B91884 given in the left thigh on 12/01/97 and unreported site on 02/16/98; lot 01164W given in the left thigh on 04/20/98; lot not legible for dose given in the left arm on 05/03/99), ActHib (lot 78916D given in the right thigh on 12/01/97; lot and manufacturer not reported for dose given 02/16/98; lot 09274W given in the right thigh on 04/10/98) and PPD (lot not reported); result negative. No further info is available.  A 15-day follow up report received 05/20/2003 adds: Follow up info was received on 05/01/2003 that reported the pt received injections that were alleged to contain thimerosal on the following dates: 12/01/1997, 02/16/1998, 04/20/1998, 06/25/1998 (reported as 06/23/1998 on immunization records), 09/28/1998, 05/03/1999 and 12/07/1999. Upon internal review, toxic neurologic effect and mercury poisoning were considered other important medical events. No further info is available.
Patient was given pediatric pfizer as 2nd dose when she should be receiving regular Pfizer dose.
Rash (small red dots) beginning on neck. Looked like a heat rash. Fever of 102 degrees.  Rash spreads all over neck, face, arms, back.  Fever continues until following day.  Treated with ibuprofen.
pt recv vax & exp a severe fever & severe rash;pt was seen in ER & treated w/APAP w/codeine & DPH;pt exp low grade fever for 5 days w/fever reaching 102 on 5th day maculopapular rash, irritability;seen in ER;
Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 06-Jul-2022; No adverse event; Administered the vaccine after the 30 day by use date; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day by use date), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 06-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 61-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 06-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 06-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day by use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 06-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day by use date), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 06-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day by use date) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 06-Jul-2022).    No concomitant medications were reported.   The patient received half dose. The vial did not undergo any temperature excursions.  No treatment details were reported.
No adverse events, but second high dose flu this season (first on 9/23/21)
died after getting the shot.; Initial information received on 16-Feb-2022 regarding an unsolicited valid Social Media serious case received from a consumer/non-hcp (non health care professional).  This case involves a patient with unknown demographics who died after getting the shot. while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect INFLUENZA VACCINE produced by unknown manufacturer, dose, lot number, route not reported in unknown administration site for immunization.  On an unknown date the patient died after getting the shot (death) (unknown latency) following the administration of INFLUENZA VACCINE. This event was assessed as medically significant and was leading to death.  Final diagnosis was (fatal) died after getting the shot..  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the event (died after getting the shot.).  At time of reporting, the outcome was Fatal for the event died after getting the shot..  It is unknown if an autopsy was done. The cause of death was reported as Death NOS (not otherwise specified).; Sender's Comments: Sanofi company comment dated 21-Feb-2022: This case involves a patient with unknown demographics who died after getting the shot. while receiving vaccine INFLUENZA VACCINE. Time to onset of the event is unknown. Information regarding condition at the time of vaccination, therapy details, latency, medical history, concomitant medications, autopsy findings would be needed to rule out any alternative etiologies. Based on the reported information, role of the individual vaccine cannot be assessed.; Reported Cause(s) of Death: died after getting the shot.
About 19 days after taking the vaccine, I had a menstrual period at the age of 69. This period was just like the ones I had when I was young except a bit lighter and lasted about six days, then stopped.  I had no other symptoms and now I'm fine.  I have no other explanation for this except for the vaccine, after which I was very tired for several days.  I also had COVID 19 in late Sept/October for which I was treated with Paxlovid, which helped tremendously.  I feel certain that the period was caused by the vaccine and the illness.  I am a retired RN with 43 years of experience.
very bad abdomen pain and back kidney area pain  chills and weakness for 24 hours and still four days later very week and unable to do much activity